M. Laird Forrest

M. Laird Forrest

University of Kansas

H-index: 41

North America-United States

About M. Laird Forrest

M. Laird Forrest, With an exceptional h-index of 41 and a recent h-index of 26 (since 2020), a distinguished researcher at University of Kansas,

His recent articles reflect a diverse array of research interests and contributions to the field:

Glatiramer acetate enhances tumor retention and mitigates systemic toxicity of toll-like receptor 9 agonists as intratumoral immunotherapy

Bioenergetically active esters for health and disease

Design of a tumor binding GMCSF as intratumoral immunotherapy of solid tumors

Pharmacokinetic Behaviors of Orally Administered Drugs

Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of …

Accelerated neutral atom beam (ANAB) and gas clustered ion beam (GCIB) treatment of implantable device polymers leads to decreased bacterial attachment in vitro and decreased …

Conformational changes and drivers of monoclonal antibody liquid-liquid phase separation

A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors

M. Laird Forrest Information

University

Position

___

Citations(all)

8668

Citations(since 2020)

3353

Cited By

6776

hIndex(all)

41

hIndex(since 2020)

26

i10Index(all)

89

i10Index(since 2020)

68

Email

University Profile Page

University of Kansas

Google Scholar

View Google Scholar Profile

Top articles of M. Laird Forrest

Title

Journal

Author(s)

Publication Date

Glatiramer acetate enhances tumor retention and mitigates systemic toxicity of toll-like receptor 9 agonists as intratumoral immunotherapy

Cancer Research

Huan Gong

Daniel J Griffin

Chad E Groer

Xiaoqing Wu

Moustafa M Abdelaziz

...

2024/3/22

Bioenergetically active esters for health and disease

2024/4/9

Design of a tumor binding GMCSF as intratumoral immunotherapy of solid tumors

Molecular Pharmaceutics

Aparna Raghavachar Chakravarti

Chad E Groer

Huan Gong

Vivian Yudistyra

Marcus Laird Forrest

...

2023/2/24

Pharmacokinetic Behaviors of Orally Administered Drugs

Oral Bioavailability and Drug Delivery: From Basics to Advanced Concepts and Applications

Hamdah Al Nebaihi

Dion R Brocks

Jaime A Yáñez

Marcus Laird Forrest

Neal M Davies

2023/10/10

Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of …

ACS Pharmacology & Translational Science

Raghu S Pandurangi

Orsolya Cseh

Hema Artee Luchman

Cynthia Xiuguang Ma

Sanjeewa N Senadheera

...

2023/2/6

Accelerated neutral atom beam (ANAB) and gas clustered ion beam (GCIB) treatment of implantable device polymers leads to decreased bacterial attachment in vitro and decreased …

Engineered Regeneration

Joseph Khoury

Ti Zhang

David B Earle

M Laird Forrest

2023/9/1

Conformational changes and drivers of monoclonal antibody liquid-liquid phase separation

Journal of pharmaceutical sciences

Nicholas R Larson

Yangjie Wei

Thayana Araújo Cruz

Reza Esfandiary

Cavan K Kalonia

...

2023/3/1

A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors

Translational Medicine Communications

Joaquina C Baranda

Ghulam Rehman Mohyuddin

Andrés M Bur

Yelizaveta Shnayder

Kyle R Sweeney

...

2023/2/27

Ultrasound-enhanced laser thrombolysis with endovascular laser and high-intensity focused ultrasound

2022/3/10

Hyaluronic acid carrier-based photodynamic therapy for head and neck squamous cell carcinoma

Photodiagnosis and photodynamic therapy

Ti Zhang

Moustafa M Abdelaziz

Shuang Cai

Xinmai Yang

Daniel J Aires

...

2022/3/1

pH-dependent phase behavior and stability of cationic lipid–mRNA nanoparticles

Journal of Pharmaceutical Sciences

Nicholas R Larson

Gang Hu

Yangjie Wei

Anthony D Tuesca

M Laird Forrest

...

2022/3/1

Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1

Molecular Pharmaceutics

Aric Huang

Chad Groer

Ruolin Lu

M Laird Forrest

J Daniel Griffin

...

2022/10/25

Platinum (IV) conjugates and methods of use

2022/10/4

Imidazoquinoline compounds and prodrugs thereof

2022/6/9

Cancer immunotherapy from biology to nanomedicine

Salma B Abdelbaky

Mayar Tarek Ibrahim

Hebatallah Samy

Menatalla Mohamed

Hebatallah Mohamed

...

2021/8/10

Glatiramer acetate enhances tumor retention and innate activation of immunostimulants

International Journal of Pharmaceutics

Melissa M Pressnall

Aric Huang

Chad E Groer

Sebastian G Huayamares

M Laird Forrest

...

2021/8/10

The feasibility of ultrasound‐assisted endovascular laser thrombolysis in an acute rabbit thrombosis model

Medical physics

Rohit Singh

Janggun Jo

Matthew Riegel

M Laird Forrest

Xinmai Yang

2021/8

Ultrasound‐assisted laser thrombolysis with endovascular laser and high‐intensity focused ultrasound

Medical physics

Janggun Jo

M Laird Forrest

Xinmai Yang

2021/2

Analysis of N15-rat growth hormone after incubation with rat subcutaneous tissue and immune cells using ultra-pressure chromatography-mass spectrometry

Analytical biochemistry

Ninad Varkhede

Peters Björn-Hendrik

K Ryan Moulder

Philip Gao

Christian Schöneich

...

2021/12/1

Polyethylene Glycol Polyester Block Copolymers: Biocompatible Carriers for Nanoparticulate Drug Delivery

David S Hart

Yunqi Zhao

M Laird Forrest

2021/1/25

See List of Professors in M. Laird Forrest University(University of Kansas)

Co-Authors

H-index: 67
Glen S Kwon

Glen S Kwon

University of Wisconsin-Madison

H-index: 60
Cory Berkland

Cory Berkland

University of Kansas

H-index: 48
Daniel W Pack

Daniel W Pack

University of Kentucky

academic-engine